IP Library › Granted Patent US 12,161,843
Granted Patent B2
US 12,161,843 · App. 17/057,558 · Granted Dec 10, 2024

Automatic drug delivery device

Inventors: Jacques Appy (Schlierbach, FR); Andrew Bryant (Buggingen, DE); Neil Cammish (Manchester, GB); Congyi Huang (Klagenfurt, AT); John Palmer-Felgate (Horsham, GB); Claudio Rossi (Elinsbach, CH); Oliver Shergold (Bolligen, CH); Gianluca Tordi (Derendingen, CH); Adrian Francios Von Muralt (Basel, CH); Mark Horlock (Cheshire, GB)
Assignee: Novartis AG
A61M5/2033A61M5/19A61M5/20A61M5/24A61M5/3157A61M5/3202A61M5/3204A61M5/3234A61M2005/2013A61M2005/3267A61M2205/581A61M2205/582A61M2205/583A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,161,843
App. No.
17/057,558
Granted
Dec 10, 2024
Kind
B2
Abstract

An automatic drug delivery device, for dispensing a fluid medicament, includes: a longitudinal housing; a removable cap; a syringe assembly having a hollow syringe body and an injection needle; and a drive mechanism. The loaded drive mechanism is operatively coupled with a safety shield movable within the longitudinal housing. The safety shield is biased into a proximal position in which it protrudes out of the proximal end of the longitudinal housing in order to cover a needle tip of the injection needle. The safety shield is movable into a distal position in which the injection needle is exposed for injection. The device includes a feedback mechanism providing a visual feedback to the user indicating an actual state of operation. The feedback mechanism includes a visual indicator which appears in a transparent window on the distal end of the housing.

Claims (62)

1. An automatic drug delivery device for dispensing a fluid product, the automatic drug delivery device comprising:

(a) a longitudinal housing extending along a longitudinal axis and having a proximal end close to a dispensing site, a distal end opposite to the proximal end and a hollow interior;

(b) a removable cap mountable to the proximal end of the housing;

(c) a syringe assembly arranged in a mounting position inside the housing and having a hollow syringe body and an injection needle formed with the hollow syringe body including the fluid product;

(d) a drive mechanism configured to be triggered by a trigger element in order to initiate dispensing of the fluid product;

wherein the drive mechanism is operatively coupled with a safety shield movable within the longitudinal housing,

wherein the safety shield is biased by a safety shield spring into a proximal position in which the safety shield protrudes out of the proximal end of the longitudinal housing in order to cover a needle tip of the injection needle, and wherein the safety shield is movable into a distal position in which the injection needle is exposed for injection;

the automatic drug delivery device further including a feedback mechanism configured to provide a visual feedback to a user indicating an actual state of operation, wherein the feedback mechanism includes a visual indicator configured to appear in a transparent window on the distal end of the housing,

wherein the visual indicator comprises a shield retention indicator member releasably held in a non-visible position in which an indication surface is not visible through the transparent window of the housing, wherein the shield retention indicator member is biased in a distal direction by the safety shield spring such that the shield retention indicator member is configured to move, when released, into a visible position in which the indication surface is visible through the transparent window of the housing.

2. The automatic drug delivery device as claimed in claim 1 , wherein the visual indicator is configured to appear in the transparent window on the distal end of the housing to indicate an end of injection.

3. The automatic drug delivery device as claimed in claim 1 , wherein the visual indicator is configured to move distally to appear in the transparent window.

4. The automatic drug delivery device as claimed in claim 1 , wherein a lock ring is provided within the longitudinal housing in an initial position, wherein the lock ring is configured to be locked to the safety shield during operation and wherein the lock ring is configured to block movement of the safety shield in a distal direction, when the safety shield covers the injection needle after the fluid product is finally dispensed and the automatic drug delivery device has been removed from an injection site.

5. The automatic drug delivery device as claimed in claim 1 ,

wherein the safety shield has at least one longitudinal arm extending in a distal direction guided within the longitudinal housing, wherein the safety shield is configured to interact with the safety shield spring biasing the safety shield in a proximal direction via the at least one longitudinal arm and wherein the safety shield spring is supported between a shield retention trigger member and the shield retention indicator member, wherein the shield retention trigger member supports a proximal end of the safety shield spring and is configured to apply a biasing force to a distal end of the at least one longitudinal arm of the safety shield, and wherein the shield retention indicator member supports a distal end of the safety shield spring.

6. The automatic drug delivery device as claimed in claim 5 , wherein the safety shield is configured to move the shield retention trigger member in the distal direction when the safety shield is being pushed in the distal direction for the purpose of initiating dispensing the fluid product, such that the shield retention trigger member compresses the safety shield spring, wherein after a predetermined stroke of the safety shield, the shield retention trigger member is configured to cause a release of the plunger from a retainer to move under the biasing force of the drive spring in the proximal direction in order to dispense the fluid product from the syringe body through the injection needle.

7. The automatic drug delivery device as claimed in claim 6 , wherein the shield retention indicator includes at least one longitudinal holding arm, wherein the shield retention indicator is held by the at least one longitudinal holding arm in a non-visible position by the retainer, in which an indication surface is not visible through the housing, wherein the at least one longitudinal holding arm is held as long as the plunger has not reached a predetermined dispensing position, wherein the plunger is configured to cause the release of the at least one longitudinal holding arm from the retainer when reaching a predetermined dispensing position, and wherein after release of the at least one longitudinal holding arm the shield retention indicator is configured to be pushed by the safety shield spring to a visible position, in which the indication surface is visible through the housing.

8. The automatic drug delivery device as claimed in claim 7 , wherein the shield retention indicator is configured to prevent distal movement of the shield retention trigger member and the shield retention trigger member is configured to prevent distal movement of the safety shield when the shield indicator member is released and has moved to the visible position and the safety shield has been biased to a position in which the safety shield covers the needle tip.

9. The automatic drug delivery device as claimed in claim 6 , wherein proximal movement of the safety shield is prevented after release of the plunger from the retainer until the plunger reaches a predetermined dispensing position.

10. An automatic drug delivery device for dispensing a fluid product, the automatic drug delivery device comprising:

(a) a longitudinal housing extending along a longitudinal axis and having a proximal end close to a dispensing site, a distal end opposite to the proximal end and a hollow interior;

(b) a removable cap mountable to the proximal end of the housing;

(c) a syringe assembly arranged in a mounting position inside the housing and having a hollow syringe body and an injection needle formed with the hollow syringe body including the fluid product;

(d) a drive mechanism configured to be triggered by a trigger element in order to initiate dispensing of the fluid product;

wherein the drive mechanism is operatively coupled with a safety shield movable within the longitudinal housing,

wherein the safety shield is biased into a proximal position in which the safety shield protrudes out of the proximal end of the longitudinal housing in order to cover a needle tip of the injection needle, and wherein the safety shield is movable into a distal position in which the injection needle is exposed for injection;

the automatic drug delivery device further including a feedback mechanism configured to provide a visual feedback to a user indicating an actual state of operation, wherein the feedback mechanism includes a visual indicator configured to appear in a transparent window on the distal end of the housing,

wherein the visual indicator is formed by a radial inner indicator component and a radial outer indicator component biased by an indicator spring into an indicator position, wherein the indicator is configured to be released into the indicator position shortly before a predetermined dose of the drug is finished being delivered to a patient.

11. The automatic drug delivery device as claimed in claim 10 , wherein the radial outer indicator component includes a visible surface and wherein the radial inner indicator component is configured to interact with the housing or an additional housing part for providing an audible and/or tactile signal.

12. An automatic drug delivery device for dispensing a fluid product, the automatic drug delivery device comprising:

(a) a longitudinal housing extending along a longitudinal axis and having a proximal end close to a dispensing site, a distal end opposite to the proximal end and a hollow interior;

(b) a removable cap mountable to the proximal end of the housing;

(c) a syringe assembly arranged in a mounting position inside the housing and having a hollow syringe body and an injection needle formed with the hollow syringe body including the fluid product;

(d) a drive mechanism configured to be triggered by a trigger element in order to initiate dispensing of the fluid product;

wherein the drive mechanism is operatively coupled with a safety shield movable within the longitudinal housing,

wherein the safety shield is biased into a proximal position in which the safety shield protrudes out of the proximal end of the longitudinal housing in order to cover a needle tip of the injection needle, and wherein the safety shield is movable into a distal position in which the injection needle is exposed for injection;

the automatic drug delivery device further including a feedback mechanism configured to provide a visual feedback to a user indicating an actual state of operation, wherein the feedback mechanism includes a visual indicator configured to appear in a transparent window on the distal end of the housing,

wherein the window is transparent around an entire circumference of the automatic drug delivery device such that the visual indicator is configured to appear in an angular range of up to 360°.

13. The automatic drug delivery device as claimed in claim 12 , further comprising a distal endcap closed by a distal surface, wherein the distal endcap is formed from a transparent material to define the transparent window.

14. The automatic drug delivery device as claimed in claim 13 , wherein the distal surface is formed from a transparent material.

15. An automatic drug delivery device for dispensing a fluid product, the automatic drug delivery device comprising:

(a) a longitudinal housing extending along a longitudinal axis and having a proximal end close to a dispensing site, a distal end opposite to the proximal end and a hollow interior;

(b) a removable cap mountable to the proximal end of the housing;

(c) a syringe assembly arranged in a mounting position inside the housing and having a hollow syringe body and an injection needle formed with the hollow syringe body including the fluid product;

(d) a drive mechanism configured to be triggered by a trigger element in order to initiate dispensing of the fluid product;

wherein the drive mechanism is operatively coupled with a safety shield movable within the longitudinal housing,

wherein the safety shield is biased into a proximal position in which the safety shield protrudes out of the proximal end of the longitudinal housing in order to cover a needle tip of the injection needle, and wherein the safety shield is movable into a distal position in which the injection needle is exposed for injection;

the automatic drug delivery device further including a feedback mechanism configured to provide a visual feedback to a user indicating an actual state of operation, wherein the feedback mechanism includes a visual indicator configured to appear in a transparent window on the distal end of the housing,

wherein a lock ring is provided within the longitudinal housing in an initial position, wherein the lock ring is configured to be locked to the safety shield during operation and wherein the lock ring is configured to block movement of the safety shield in a distal direction, when the safety shield covers the injection needle after the fluid product is finally dispensed and the automatic drug delivery device has been removed from an injection site,

wherein the lock ring in the initial state is held by a receiving component holding the syringe holder, wherein the lock ring is configured to engage with the safety shield, after the safety shield has been pushed in the distal direction, wherein the lock ring is configured to be moved with the safety shield in a proximal direction when removing the automatic drug delivery device from the injection site, and wherein the lock ring is configured to block any movement of the safety shield against the receiving component in the distal direction when covering the injection needle after use.

16. An automatic drug delivery device for dispensing a fluid product, the automatic drug delivery device comprising:

(a) a longitudinal housing extending along a longitudinal axis and having a proximal end close to a dispensing site, a distal end opposite to the proximal end and a hollow interior;

(b) a removable cap mountable to the proximal end of the housing;

(c) a syringe assembly arranged in a mounting position inside the housing and having a hollow syringe body and an injection needle formed with the hollow syringe body including the fluid product;

(d) a drive mechanism configured to be triggered by a trigger element in order to initiate dispensing of the fluid product;

wherein the drive mechanism is operatively coupled with a safety shield movable within the longitudinal housing,

wherein the safety shield is biased into a proximal position in which the safety shield protrudes out of the proximal end of the longitudinal housing in order to cover a needle tip of the injection needle, and wherein the safety shield is movable into a distal position in which the injection needle is exposed for injection;

the automatic drug delivery device further including a feedback mechanism configured to provide a visual feedback to a user indicating an actual state of operation, wherein the feedback mechanism includes a visual indicator configured to appear in a transparent window on the distal end of the housing,

wherein the safety shield has at least one longitudinal arm extending in a distal direction guided within the longitudinal housing, wherein the safety shield is configured to interact with a safety shield spring biasing the safety shield in a proximal direction via the at least one longitudinal arm and wherein the safety shield spring is supported between a shield retention trigger member and a shield retention indicator member, wherein the shield retention trigger member supports a proximal end of the safety shield spring and is configured to apply a biasing force to a distal end of the at least one longitudinal arm of the safety shield, and wherein the shield retention indicator member supports a distal end of the safety shield spring.

17. The automatic drug delivery device as claimed in claim 16 , wherein the safety shield is configured to move the shield retention trigger member in the distal direction when the safety shield is being pushed in the distal direction for the purpose of initiating dispensing the fluid product, such that the shield retention trigger member compresses the safety shield spring, wherein after a predetermined stroke of the safety shield, the shield retention trigger member is configured to cause a release of the plunger from a retainer to move under the biasing force of the drive spring in the proximal direction in order to dispense the fluid product from the syringe body through the injection needle.

18. The automatic drug delivery device as claimed in claim 17 , wherein the shield retention indicator includes at least one longitudinal holding arm, wherein the shield retention indicator is held by the at least one longitudinal holding arm in a non-visible position by the retainer, in which an indication surface is not visible through the housing, wherein the at least one longitudinal holding arm is held as long as the plunger has not reached a predetermined dispensing position, wherein the plunger is configured to cause the release of the at least one longitudinal holding arm from the retainer when reaching a predetermined dispensing position, and wherein after release of the at least one longitudinal holding arm the shield retention indicator is configured to be pushed by the safety shield spring to a visible position, in which the indication surface is visible through the housing.

19. The automatic drug delivery device as claimed in claim 18 , wherein the shield retention indicator is configured to prevent distal movement of the shield retention trigger member and the shield retention trigger member is configured to prevent distal movement of the safety shield when the shield indicator member is released and has moved to the visible position and the safety shield has been biased to a position in which the safety shield covers the needle tip.

20. The automatic drug delivery device as claimed in claim 17 , wherein proximal movement of the safety shield is prevented after release of the plunger from the retainer until the plunger reaches a predetermined dispensing position.

Assignments (16)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: BRYANT, ANDREW; CAMMISH, NEIL; HORLOCK, MARK
To: NOVARTIS PHARMA AG
Reel/Frame 055855/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: PALMER-FELGATE, JOHN
To: NOVARTIS PHARMA AG
Reel/Frame 055855/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 055855/0925 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: HUANG, CONGYI
To: SANDOZ GMBH
Reel/Frame 055856/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: SANDOZ GMBH
To: NOVARTIS AG
Reel/Frame 055856/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: PALMER-FELGATE, JOHN
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0380 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: APPY, JACQUES; CAMMISH, NEIL; HORLOCK, MARK; ROSSI, CLAUDIO; SHERGOLD, OLIVER; TORDI, GIANLUCA; VON MURALT, ADRIAN FRANCOIS
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 055856/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: HUANG, CONGYI
To: SANDOZ GMBH
Reel/Frame 055856/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: SANDOZ GMBH
To: NOVARTIS AG
Reel/Frame 055856/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: PALMER-FELGATE, JOHN
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: CAMMISH, NEIL; HORLOCK, MARK; ROSSI, CLAUDIO; SHERGOLD, OLIVER
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0693 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 055856/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: PALMER-FELGATE, JOHN
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0727 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: APPY, JACQUES; CAMMISH, NEIL; HORLOCK, MARK; ROSSI, CLAUDIO; SHERGOLD, OLIVER
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0739 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: NOVARTIS PHARMA AG
To: NOVARTIS PHARMA AG
Reel/Frame 055856/0761 →
Priority Claims (4)
EP 18174181 · May 24, 2018 · regional
EP 18174183 · May 24, 2018 · regional
EP 18174190 · May 24, 2018 · regional
GB 1808598 · May 24, 2018 · national
Continuity (1)
Related Publication 20210196894A1 · Jul 1, 2021